Gastric Cancer

• CLINICAL_TRIALS trial_result · 2025-05-09
  Clinical Trial Update: Clinical Study on the Treatment of Anorexia and Cachexia in Advanced Gastric and Esophageal Cancer With Nanosized Megestrol Acetate Combined With Immunochemotherapy [Phase 4]

  A Phase 4 clinical trial from Peking University is evaluating nanosized Megestrol Acetate combined with immunochemotherapy to treat anorexia…

• CLINICAL_TRIALS trial_result · 2025-05-08
  Clinical Trial Update: Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]

  The Phase 1/2 trial of surufatinib in combination with tislelizumab for advanced solid tumors has been terminated. Results were posted on 20…

• CLINICAL_TRIALS trial_result · 2025-05-06
  Clinical Trial Update: A Study to Evaluate Safety, Tolerability, Dosimetry, and Preliminary Efficacy of the HER2 Directed Radioligand CAM-H2 in Patients With Advanced/Metastatic HER2-Positive Breast, Gastric, and Gastro-Esophageal Junction (GEJ) Cancer [Phase 1, Phase 2]

  A phase 1/2 study evaluating CAM-H2, a HER2-directed radioligand, in advanced/metastatic HER2-positive breast, gastric, and gastroesophageal…

• CLINICAL_TRIALS trial_result · 2025-04-27
  Clinical Trial Update: Perianastomotic Drain After Gastrectomy (DRAG) [NA]

  The DRAG trial assessing perianastomotic drain after gastrectomy for gastric cancer has completed, with results posted on 2025-04-27.

• CLINICAL_TRIALS trial_result · 2025-04-27
  Clinical Trial Update: Radiomics-Based AI Model for Predicting Para-Aortic Lymph Node Metastasis in Gastric Cancer Patients

  A clinical trial is enrolling by invitation to develop and validate a radiomics-based AI model to predict para-aortic lymph node metastasis …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2025-04-27
  Clinical Trial Update: LIQUID BIOPSY FOCUSING ON CIRCULATING TUMOR CELLS AND CIRCULATING TUMOR DNA AS PRECISION MEDICINE IN GASTROINTESTINAL TUMORS

  A clinical trial update describes using liquid biopsies of circulating tumor cells and circulating tumor DNA to guide precision medicine in …

• CLINICAL_TRIALS trial_result · 2025-04-23
  Clinical Trial Update: Potential Advantages of Robotic Total Gastrectomy in Advanced Middle-Upper Gastric Cancer: A Multicenter Propensity Score Matching Analysis

  A multicenter propensity score-matched analysis assesses the potential advantages of robotic total gastrectomy for advanced middle-upper gas…

• CLINICAL_TRIALS trial_result · 2025-04-22
  Clinical Trial Update: Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer [Phase 2, Phase 3]

  This clinical trial update reports the completion of a Phase 2/3 study evaluating a four-drug combination (margetuximab, retifanlimab, tebot…

• CLINICAL_TRIALS trial_result · 2025-04-22
  Clinical Trial Update: A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors [Phase 1]

  This clinical trial update reports the completion of a Phase 1 study of CEA-targeted CAR-T therapy for CEA-positive advanced solid tumors, i…

• CLINICAL_TRIALS trial_result · 2025-04-17
  Clinical Trial Update: Perioperative mFOLFOX-6 in Locally Advanced Gastric Cancer [Phase 2]

  Phase 2 trial evaluating perioperative mFOLFOX-6 for locally advanced gastric cancer has completed. The update provides trial status and con…

• CLINICAL_TRIALS trial_result · 2025-04-16
  Clinical Trial Update: Lenvatinib and Pembrolizumab Simultaneous Combination Study [Phase 2]

  Phase 2 study evaluating the combination of lenvatinib and pembrolizumab in advanced gastric cancer has completed, with results posted on 20…

• CLINICAL_TRIALS trial_result · 2025-04-16
  Clinical Trial Update: A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer [Phase 1, Phase 2]

  A completed Phase 1/2 study evaluated IMU-131 (HER-Vaxx) in combination with chemotherapy versus chemotherapy alone in HER2-positive advance…

• CLINICAL_TRIALS trial_result · 2025-04-13
  Clinical Trial Update: Effect of Smart Phone App-based Human Coaching Program in Gastrectomized Patients [NA]

  This document reports the completed status of a clinical trial evaluating a smartphone app-based human coaching program for patients who hav…

• CLINICAL_TRIALS trial_result · 2025-04-08
  Clinical Trial Update: Comparison of Tumor Efficacy Safety in Laparoscopic Resection of Gastrointestinal Stromal Tumors Between Favorable and Unfavorable Site

  Clinical trial update on a study comparing tumor efficacy and safety of laparoscopic resection for gastrointestinal stromal tumors of the st…

• CLINICAL_TRIALS trial_result · 2025-04-04
  Clinical Trial Update: The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer [NA]

  The RIOT trial evaluating prehabilitation to reduce frailty and improve outcomes in pancreatic, liver, and gastric cancer has completed.

• CLINICAL_TRIALS trial_result · 2025-04-02
  Clinical Trial Update: Feasibility Study of Sentinel Navigation Surgery After Non-curative Endoscopic Resection [NA]

  A completed feasibility study evaluating sentinel navigation surgery after non-curative endoscopic resection for early gastric cancer.

• CLINICAL_TRIALS trial_result · 2025-04-02
  Clinical Trial Update: A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies [Phase 1, Phase 2]

  Phase 1/2 open-label study evaluating Alomfilimab (KY1044) alone and with atezolizumab in multiple advanced cancers. The trial was terminate…

• CLINICAL_TRIALS trial_result · 2025-04-01
  Clinical Trial Update: Camrelizumab Combined with Apatinib Mesylate Tablets, Nab-paclitaxel and S-1 in the Treatment of Locally Advanced Gastric Cancer [Phase 2]

  Phase 2 trial evaluating camrelizumab in combination with apatinib, nab-paclitaxel, and S-1 for locally advanced gastric cancer has complete…

• CLINICAL_TRIALS trial_result · 2025-04-01
  Clinical Trial Update: Concomitant Intraperitoneal and Systemic Chemotherapy in Patients With Extensive Peritoneal Carcinomatosis of Gastric Origin [Phase 1]

  This clinical trial update reports the completion of a Phase 1 study evaluating concomitant intraperitoneal and systemic chemotherapy for pa…

• CLINICAL_TRIALS trial_result · 2025-03-30
  Clinical Trial Update: A Trial of SHR1701 Plus Chemotherapy in Patients With Gastric or Gastroesophageal Cancer [Phase 3]

  Phase 3 trial of SHR1701 plus chemotherapy for gastric or gastroesophageal junction cancer is currently active but not recruiting.

• CLINICAL_TRIALS trial_result · 2025-03-27
  Clinical Trial Update: OPPOSITE: Outcome Prediction of Systemic Treatment in Esophagogastric Carcinoma [NA]

  Clinical trial OPPOSITE, studying outcome prediction of systemic treatment in esophagogastric carcinoma, has completed. The sponsor is Unive…

• CLINICAL_TRIALS trial_result · 2025-03-25
  Clinical Trial Update: Vactosertib in Combination with Pembrolizumab in Metastatic Colorectal or Gastric Cancer [Phase 1, Phase 2]

  Clinical trial update on Vactosertib combined with pembrolizumab for metastatic colorectal cancer and gastric/gastroesophageal junction aden…

• CLINICAL_TRIALS trial_result · 2025-03-20
  Clinical Trial Update: PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) [NA]

  PLATON, a platform for analyzing targetable tumor mutations, completed its pilot study evaluating its utility across hepatocellular carcinom…

• CLINICAL_TRIALS trial_result · 2025-03-19
  Clinical Trial Update: Safety and Efficacy of Single or Reduced Ports Laparoscopic Gastrectomy for Advanced Gastric Cancer (SPACE-01) [NA]

  This clinical trial update describes SPACE-01, a study evaluating single- or reduced-port laparoscopic gastrectomy for advanced gastric canc…

• CLINICAL_TRIALS trial_result · 2025-03-18
  Clinical Trial Update: Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer [Phase 2]

  A phase 2 study evaluating tislelizumab plus apatinib, oxaliplatin, and S-1 as neoadjuvant therapy for advanced gastric cancer (Borrmann typ…